[HTML][HTML] Impact of early corticosteroids on preventing clinical deterioration in non-critically ill patients hospitalized with COVID-19: a multi-hospital cohort study

L Swaminathan, S Kaatz, H Chubb, K Tae… - Infectious Diseases and …, 2022 - Springer
Introduction While guidelines stronglyrecommend dexamethasone in critical COVID-19, the
optimal threshold to initiate corticosteroids in non-critically ill patients with COVID-19 …

Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study

L Swaminathan, S Kaatz, H Chubb… - Infect Dis …, 2022 - scholarlycommons.henryford.com
INTRODUCTION: While guidelines strongly recommend dexamethasone in critical COVID-
19, the optimal threshold to initiate corticosteroids in non-critically ill patients with COVID-19 …

[PDF][PDF] Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study

L Swaminathan, SKH Chubb, KTMSR Raef, FC Big… - 2022 - scienceopen.com
Introduction: While guidelines stronglyrecommend dexamethasone in critical COVID-19, the
optimal threshold to initiate corticosteroids in non-critically ill patients with COVID-19 …

Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study.

L Swaminathan, S Kaatz, H Chubb, K Tae… - Infectious Diseases …, 2022 - europepmc.org
Methods This was a target trial using observational data from patients hospitalized for
COVID-19 at 39 hospitals participating in the MI-COVID19 registry between March 16, 2020 …

Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study.

L Swaminathan, S Kaatz, H Chubb… - Infectious …, 2022 - scholarlyworks.beaumont.org
INTRODUCTION: While guidelines stronglyrecommend dexamethasone in critical COVID-
19, the optimal threshold to initiate corticosteroids in non-critically ill patients with COVID-19 …

Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study

L Swaminathan, S Kaatz, H Chubb, K Tae, MS Ramesh… - 2022 - deepblue.lib.umich.edu
Introduction While guidelines stronglyrecommend dexamethasone in critical COVID-19, the
optimal threshold to initiate corticosteroids in non-critically ill patients with COVID-19 …

[HTML][HTML] Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study

L Swaminathan, S Kaatz, H Chubb, K Tae… - Infectious Diseases …, 2022 - ncbi.nlm.nih.gov
Methods This was a target trial using observational data from patients hospitalized for
COVID-19 at 39 hospitals participating in the MI-COVID19 registry between March 16, 2020 …

Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study

L Swaminathan, S Kaatz, H Chubb… - Infectious diseases …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction While guidelines stronglyrecommend dexamethasone in critical COVID-19, the
optimal threshold to initiate corticosteroids in non-critically ill patients with COVID-19 …

Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study

L Swaminathan, S Kaatz, H Chubb… - Infectious Diseases …, 2022 - search.proquest.com
Methods This was a target trial using observational data from patients hospitalized for
COVID-19 at 39 hospitals participating in the MI-COVID19 registry between March 16, 2020 …

Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study.

L Swaminathan, S Kaatz, H Chubb, K Tae… - Infectious Diseases …, 2022 - europepmc.org
Methods This was a target trial using observational data from patients hospitalized for
COVID-19 at 39 hospitals participating in the MI-COVID19 registry between March 16, 2020 …